£685 / $1095 / €820
These days we all suffer from information overload; by focusing specifically on CNS drugs, the CNS Drug News online service will deliver the information you need in a timely, flexible and convenient format.
An ageing population and ever better rates of diagnosis is seeing the incidence of major CNS sectors rise considerably – particularly demanding are the neurodegenerative conditions. Even so, levels of unmet clinical need remain high and growth is expected to continue.
For pharmaceutical company executives, researchers and commercial managers, staying in touch with the latest twists and turns is another matter. That is why CNS Drug News is essential.
The CNS Drug News service provides unbeatable coverage:
Every day, Espicom’s researchers and editors
The CNS Drug News online information service is updated regularly. CNS Drug News is also available in pdf format, providing a twice-monthly digest (minimum 22 issues per year) of the news published online.
Cost-effective multi-user distribution deals means the service can be used widely by colleagues in your organisation – contact firstname.lastname@example.org for details, alternatively you can use our contact us page.